UNITED STATES CARISBAMATE EXPANDED ACCESS PROGRAM (EAP) TREATMENT GUIDELINES FOR PATIENTS WITH LENNOX-GASTAUT SYNDROME (LGS)
Principal Investigator
Study Number
STUDY02001626
Phase
N/A
Contact
Available at the following location(s)
- Lebanon
Do you need help with some of the labels on this page?
Read our glossary of terms